Best Agrolife Ltd
NSE:BESTAGRO

Watchlist Manager
Best Agrolife Ltd Logo
Best Agrolife Ltd
NSE:BESTAGRO
Watchlist
Price: 19.53 INR 4.77% Market Closed
Market Cap: ₹6.9B

Best Agrolife Ltd
Investor Relations

Best Agrolife Ltd. engages in the business of dealing in Plastic products & raw materials. The company is headquartered in New Delhi, Delhi. The company went IPO on 2016-02-17. The firm is engaged in the business of manufacturing of all kinds of technicals and formulation grade pesticides, herbicides, insecticides and other chemicals and chemical products, and industrial chemicals. The firm also supplies crop protection products. Its insecticides products include MASTERY, IRMA, MAHABALI, NOVOXA, PYMAX, DIRON, CUBAX, POROS, VIBYOR, LAKRA, and THRONE. Its herbicides products include MAJOUR, CHLORMAX, PM-32, BYJU, VYPYR, BESTIE, ATRASHAKTI, CUSTO, PENDIFAST, and PUTIN. Its fungicides products include CAPTCHA, AZOXYCURE, ZOXIT, ZODIO, TEBUCA, and BLUE WHALE. The company offers technicals, such as CYPERMETHRIN TC, DICHLORVOS TC, IMIDACLOPRID TC, INDOXACARB TC, CHLORPYRIFOS TC, FLUBENDIAMIDE, PYRIPROXYFEN TC, and SPIROMESIFEN TC. Its formulations include FORCHLORFENURON (CPPU) 0.1% LIQUID and GIBBERELLIC ACID 0.001 %L. The company offers soil conditioner, which includes MYCRORISER and MYCRORISER GOLD.

Show more
Loading
BESTAGRO
BSE Sensex 30
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2026
Call Date
Feb 9, 2026
AI Summary
Q3 2026

Revenue Drop: Quarterly and 9-month revenues declined sharply due to erratic and excessive rainfall, lower pest pressure, and weak market demand.

Margin Recovery: Despite lower sales, Q3 gross margin held at 32%, and EBITDA turned positive versus a loss last year, driven by aggressive cost and inventory controls.

Loss Reduced: Q3 net loss narrowed to INR 12.7 crores from INR 24.2 crores in Q3 FY '25; 9-month PAT also down sharply year-on-year.

Guidance: FY '26 revenue expected between INR 1,300–1,400 crores with EBITDA margin around 12%; management says the worst is likely over and expects growth to resume from next year.

Patent Portfolio Focus: Shift to higher-margin patented products continues, with new launches Best Man and Fetagen gaining strong farmer acceptance.

International Expansion: Export activity and patent registrations progressing in key markets; China subsidiary operational but international revenue still early-stage.

Capex on Hold: Planned expansion deferred until further funding clarity; current capacity sufficient for targeted revenue recovery.

Key Financials
Revenue (Q3 FY '26)
INR 202.9 crores
Gross Margin (Q3 FY '26)
INR 65 crores
Gross Margin Percentage (Q3 FY '26)
32%
EBITDA (Q3 FY '26)
INR 3.8 crores
EBITDA Margin (Q3 FY '26)
1.9%
Profit After Tax (Q3 FY '26)
INR -12.7 crores
Revenue (9M FY '26)
INR 1,101 crores
Gross Margin (9M FY '26)
INR 345 crores
EBITDA (9M FY '26)
INR 127 crores
EBITDA Margin (9M FY '26)
11.5%
Profit After Tax (9M FY '26)
INR 46.1 crores
Sales Volume Decline (9M YoY)
Down 23%
Price Variation Impact (9M YoY)
Down 5%
Patent Portfolio Sales Decline (9M YoY)
Down 5%
Non-patent Portfolio Sales Decline (9M YoY)
Down 48%
FY '26 Revenue Guidance
INR 1,300–1,400 crores
FY '26 EBITDA Margin Guidance
Around 12%
Future Revenue Target (FY '27–'28)
INR 1,600–1,800 crores
Future EBITDA Margin Target (FY '27–'28)
16–20%
Other Earnings Calls

Management

Mr. Vimal Kumar Alawadhi
MD & Director
No Bio Available
Ms. Isha Luthra
Whole-Time Women Director
No Bio Available
Mr. Balavenkatarama Prasad Suryadevara
Whole-Time Director
No Bio Available
Mr. Vikash Sohanlal Jain
Chief Financial Officer
No Bio Available
Ms. Astha Wahi
Head Company Secretary & Compliance Officer
No Bio Available
Mr. Sara Narsaiah
Chief Marketing Officer
No Bio Available
Mr. Atul Garg
Head of Commercial & Control
No Bio Available
Mr. Ajit Singh Gujral
Head of Institutional Business
No Bio Available
Mr. Suresh V. Sutar
Head of R & D
No Bio Available
Mr. Deepak Patel
Head of Formulations
No Bio Available

Contacts

Address
DELHI
New Delhi
B-4, Bhagwan Das Nagar, East Punjabi Bagh
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett